Actively Recruiting
CardioMEMS HF System Coverage With Evidence Development Study
Led by Abbott Medical Devices · Updated on 2026-04-03
1000
Participants Needed
1
Research Sites
368 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of the CardioMEMS CED Study is to determine if pulmonary artery (PA) pressure-guided heart failure management using the CardioMEMS™ HF System improves long-term health outcomes in heart failure (HF) patients in the real-world setting.
CONDITIONS
Official Title
CardioMEMS HF System Coverage With Evidence Development Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Subject implanted with a CardioMEMS pressure sensor (treatment arm only)
- Subject 18 years of age or older at time of implant
- Subject has a history of acute decompensated heart failure or heart failure-related congestion defined by at least one qualifying event: heart failure hospitalization or elevated BNP/NT-proBNP
You will not qualify if you...
- Subject has history of heart transplant or durable mechanical circulatory device
- Subject hospitalized with cardiogenic shock or sepsis
- Subject received prior pulmonary artery pressure sensor implant (control arm only)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Abbott
Pleasanton, California, United States, 94588
Actively Recruiting
Research Team
N
Nessa Johnson
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here